{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:27:09Z","timestamp":1775140029126,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,12]]},"DOI":"10.7759\/cureus.83957","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T14:35:56Z","timestamp":1747060556000},"source":"Crossref","is-referenced-by-count":1,"title":["Temporal Trends and Disparities in Chronic Liver Disease Mortality: An Analysis Using National Center for Health Statistics (NCHS) Data Ranging From 1999 to 2023"],"prefix":"10.7759","author":[{"given":"Victor C","family":"Ezeamii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwujindu I","family":"Arinzechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oghenemaro O","family":"Oghotuoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwakmfonabasi","family":"Umoudoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afolake A","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogechukwu  H","family":"Nnabude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiwo","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolaji","family":"Ayinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinelo","family":"Anyaorah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gift","family":"Ojukwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Chronic liver disease","author":"Sharma A","year":"2025","unstructured":"Sharma A, Nagalli S. Chronic liver disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","unstructured":"Liver disease. (2025). Accessed. March 10, 2025: https:\/\/my.clevelandclinic.org\/health\/diseases\/15448-liver-disease."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310633","article-title":"Chronic liver disease: Latest research in pathogenesis, detection, and treatment","volume":"24","author":"De Siervi S","year":"2023","unstructured":"De Siervi S, Cannito S, Turato C. Chronic liver disease: Latest research in pathogenesis, detection, and treatment. Int J Mol Sci. 2023, 24:10633. 10.3390\/ijms241310633","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2022.04.012","article-title":"Nutrition as therapy in liver disease","volume":"44","author":"Shah ND","year":"2022","unstructured":"Shah ND, Barritt AS. Nutrition as therapy in liver disease. Clin Ther. 2022, 44:682-96. 10.1016\/j.clinthera.2022.04.012","journal-title":"Clin Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla S","year":"2021","unstructured":"Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis (Hoboken). 2021, 17:365-70. 10.1002\/cld.1061","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon AM","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020, 18:2650-66. 10.1016\/j.cgh.2019.07.060","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm DR","year":"2022","unstructured":"Kamm DR, McCommis KS. Hepatic stellate cells in physiology and pathology. J Physiol. 2022, 600:1825-37. 10.1113\/JP281061","journal-title":"J Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi T","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017, 121:27-42. 10.1016\/j.addr.2017.05.007","journal-title":"Adv Drug Deliv Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort KR","year":"2024","unstructured":"LeFort KR, Rungratanawanich W, Song BJ. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cell Mol Life Sci. 2024, 81:34. 10.1007\/s00018-023-05061-7","journal-title":"Cell Mol Life Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091653","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh A","year":"2023","unstructured":"Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K. Oxidative stress in liver pathophysiology and disease. Antioxidants (Basel). 2023, 12:1653. 10.3390\/antiox12091653","journal-title":"Antioxidants (Basel)"},{"key":"ref11","unstructured":"CDC WONDER. Accessed. February 20, 2025: https:\/\/wonder.cdc.gov."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.02.016","article-title":"Nonalcoholic fatty liver disease and mortality","volume":"16","author":"Stefan N","year":"2018","unstructured":"Stefan N. Nonalcoholic fatty liver disease and mortality. Clin Gastroenterol Hepatol. 2018, 16:1043-5. 10.1016\/j.cgh.2018.02.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper EB","year":"2018","unstructured":"Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018, 362:k2817. 10.1136\/bmj.k2817","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1745","article-title":"Impact of COVID-19 in liver disease progression","volume":"5","author":"Martinez MA","year":"2021","unstructured":"Martinez MA, Franco S. Impact of COVID-19 in liver disease progression. Hepatol Commun. 2021, 5:1138-50. 10.1002\/hep4.1745","journal-title":"Hepatol Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.07.007","article-title":"COVID-19 and alcohol-associated liver disease","volume":"54","author":"Deutsch-Link S","year":"2022","unstructured":"Deutsch-Link S, Curtis B, Singal AK. COVID-19 and alcohol-associated liver disease. Dig Liver Dis. 2022, 54:1459-68. 10.1016\/j.dld.2022.07.007","journal-title":"Dig Liver Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2022.114038","article-title":"Sex differences matter: males and females are equal but not the same","volume":"259","author":"Ivan S","year":"2023","unstructured":"Ivan S, Daniela O, Jaroslava BD. Sex differences matter: males and females are equal but not the same. Physiol Behav. 2023, 259:114038. 10.1016\/j.physbeh.2022.114038","journal-title":"Physiol Behav"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.35946\/arcr.v40.2.01","article-title":"Gender differences in the epidemiology of alcohol use and related harms in the United States","volume":"40","author":"White AM","year":"2020","unstructured":"White AM. Gender differences in the epidemiology of alcohol use and related harms in the United States. Alcohol Res. 2020, 40:01. 10.35946\/arcr.v40.2.01","journal-title":"Alcohol Res"},{"key":"ref18","article-title":"Ethnicity and health disparities in alcohol research","volume":"33","author":"Chartier K","year":"2010","unstructured":"Chartier K, Caetano R. Ethnicity and health disparities in alcohol research. Alcohol Res Health. 2010, 33:152-60.","journal-title":"Alcohol Res Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi Z","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, et al.. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019, 69:2672-82. 10.1002\/hep.30251","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22223","article-title":"Racial disparity in liver disease: biological, cultural, or socioeconomic factors","volume":"47","author":"Nguyen GC","year":"2008","unstructured":"Nguyen GC, Thuluvath PJ. Racial disparity in liver disease: biological, cultural, or socioeconomic factors. Hepatology. 2008, 47:1058-66. 10.1002\/hep.22223","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions","volume":"21","author":"Mak LY","year":"2024","unstructured":"Mak LY, Liu K, Chirapongsathorn S, et al.. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nat Rev Gastroenterol Hepatol. 2024, 21:834-51. 10.1038\/s41575-024-00967-4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v11.i9.663","article-title":"Cirrhotic patients and older people","volume":"11","author":"Carrier P","year":"2019","unstructured":"Carrier P, Debette-Gratien M, Jacques J, Loustaud-Ratti V. Cirrhotic patients and older people. World J Hepatol. 2019, 11:663-77. 10.4254\/wjh.v11.i9.663","journal-title":"World J Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2022.09.001","article-title":"Epidemiology and disease burden of alcohol-associated liver disease","volume":"13","author":"Aslam A","year":"2023","unstructured":"Aslam A, Kwo PY. Epidemiology and disease burden of alcohol-associated liver disease. J Clin Exp Hepatol. 2023, 13:88-102. 10.1016\/j.jceh.2022.09.001","journal-title":"J Clin Exp Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359652-temporal-trends-and-disparities-in-chronic-liver-disease-mortality-an-analysis-using-national-center-for-health-statistics-nchs-data-ranging-from-1999-to-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T14:35:58Z","timestamp":1747060558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359652-temporal-trends-and-disparities-in-chronic-liver-disease-mortality-an-analysis-using-national-center-for-health-statistics-nchs-data-ranging-from-1999-to-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.83957","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}